[Clinical significance of long-acting diuretics in the treatment of cardiovascular diseases].
Taniguchi
S
S
First Department of Internal Medicine, University of Tokyo.
Kurokawa
K
K
D000086:Acetazolamide / Q000494:pharmacology / Q000627:therapeutic use*; D001581:Benzothiadiazines; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000378:metabolism; D003692:Delayed-Action Preparations; D004232:Diuretics / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D049993:Sodium Chloride Symporter Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D013148:Spironolactone / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D013449:Sulfonamides
D001581:Benzothiadiazines; D003692:Delayed-Action Preparations; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D013449:Sulfonamides; D013148:Spironolactone; D000086:Acetazolamide